National Institute on Drug Abuse; Notice of Closed Meeting, 91184 [2016-30220]
Download as PDF
91184
Federal Register / Vol. 81, No. 242 / Friday, December 16, 2016 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: December 12, 2016.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–30218 Filed 12–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, March 28, 2017, 08:30
a.m. to March 28, 2017, 05:00 p.m.,
National Institutes of Health, National
Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane, Terrace
Conference Room 508, Rockville, MD,
20892 which was published in the
Federal Register on November 29, 2016,
81FR85983.
This notice is amended to change the
meeting date from March 28, 2017 to
March 29, 2017. The meeting is closed
to the public.
Dated: December 12, 2016.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–30219 Filed 12–15–16; 8:45 am]
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Synthesis and Distribution of Opioid and
Related Peptides (7795).
Date: January 5, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Affordable Care Act (ACA) Web Platform to
Integrate Behavioral Health and Prevention
with Primary Care (5679).
Date: January 10, 2017.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: December 12, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–30220 Filed 12–15–16; 8:45 am]
BILLING CODE 4140–01–P
Notice of accreditation and
approval of Intertek USA, Inc. as a
commercial gauger and laboratory.
ACTION:
Notice is hereby given,
pursuant to CBP regulations, that
Intertek USA, Inc. has been approved to
gauge petroleum and certain petroleum
products and accredited to test
petroleum and certain petroleum
products for customs purposes for the
next three years as of May 25, 2016.
SUMMARY:
Effective Dates: The
accreditation and approval of Intertek
USA, Inc. as commercial gauger and
laboratory became effective on May 25,
2016. The next triennial inspection date
will be scheduled for May 2019.
DATES:
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Suite
1500N, Washington, DC 20229, tel. 202–
344–1060.
Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Intertek USA,
Inc., 1211 Belgrove Drive, St. Louis, MO
63137 has been approved to gauge
petroleum and certain petroleum
products and accredited to test
petroleum and certain petroleum
products for customs purposes, in
accordance with the provisions of 19
CFR 151.12 and 19 CFR 151.13. Intertek
USA, Inc. is approved for the following
gauging procedures for petroleum and
certain petroleum products from the
American Petroleum Institute (API):
SUPPLEMENTARY INFORMATION:
API chapters
3 ...................
7 ...................
8 ...................
12 .................
17 .................
Title
Tank Gauging.
Temperature Determination.
Sampling.
Calculations.
Marine Measurement.
National Institutes of Health
mstockstill on DSK3G9T082PROD with NOTICES
National Institute on Drug Abuse;
Notice of Closed Meeting
DEPARTMENT OF HOMELAND
SECURITY
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
VerDate Sep<11>2014
18:42 Dec 15, 2016
Jkt 241001
U.S. Customs and Border Protection
Accreditation and Approval of Intertek
USA, Inc., as a Commercial Gauger
and Laboratory
Intertek USA, Inc. is accredited for the
following laboratory analysis
procedures and methods for petroleum
and certain petroleum products set forth
by the U.S. Customs and Border
Protection Laboratory Methods (CBPL)
and American Society for Testing and
Materials (ASTM):
U.S. Customs and Border
Protection, Department of Homeland
Security.
AGENCY:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
E:\FR\FM\16DEN1.SGM
16DEN1
Agencies
[Federal Register Volume 81, Number 242 (Friday, December 16, 2016)]
[Notices]
[Page 91184]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30220]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Synthesis and Distribution of Opioid and Related
Peptides (7795).
Date: January 5, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Affordable Care Act (ACA) Web Platform to Integrate
Behavioral Health and Prevention with Primary Care (5679).
Date: January 10, 2017.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: December 12, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-30220 Filed 12-15-16; 8:45 am]
BILLING CODE 4140-01-P